Nicox

Developer of nitric oxide (NO) based therapeutics for glaucoma

placeValbonne, Provence Alpes Cote D Azur, France calendar_todayFounded 1996 groups28 employees language nicox.com

Social engagement

Social engagement: 5.7K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital433%
Private equity217%
Bank & private debt217%
Other / undisclosed433%

Recent activity

1 Jul 2026
Milestone
regulatory
1 Jul 2026
Partnership
regulatory
Coming soon